initial public offerings (IPOs) trading on American exchanges

Friday, November 21, 2014

INC Research Holding (INCR) began trading on the NASDAQ on 7 November 2014


INC Research Holdings Inc (INC Research) is a contract research organization (CRO). The Company is engaged in Strategic clinical development, which provides a range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry; Standalone services, such as Project management, Data and biostatistics, Monitoring, Quality and compliance, Safety and pharmacovigilance, Regulatory affairs, Study start-up, Patient recruitment, Pregnancy registries, Abuse liability, Alcohol interactions and Medical writing, and Pharmaceutical consulting. The Company operates in North America, South America, Central Europe, Southern Europe, Western Europe, Middle East, Asia Pacific and Africa. The Company uses web-based electronic endpoint adjudication systems and monitoring techniques.


3201 Beechleaf Ct Ste 600
RALEIGH, NC 27604-1500
United States

Key stats and ratios

Q3 (Sep '14)2013
Net profit margin4.20%-4.17%
Operating margin7.61%3.16%
EBITD margin-10.23%
Return on average assets3.82%-3.33%
Return on average equity17.12%-14.17%

No comments:

Post a Comment